UBS Maintains Buy on Albemarle, Lowers Price Target to $150

Benzinga Newsdesk www.benzinga.com Negative 74.5%

Neg 74.5% Neu 0% Pos 0%

UBS analyst Joshua Spector maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $175 to $150.

Comments

No comments yet. Be the first!